Urolithin A is a compound produced when gut bacteria break down ellagitannins, the polyphenols found in pomegranates, walnuts, and certain berries. Not everyone produces it efficiently — your ability to convert dietary ellagitannins into urolithin A depends heavily on your individual gut microbiome composition [8].
Over the past several years, researchers have been investigating whether urolithin A has a meaningful effect on the gut itself — specifically on the intestinal barrier, the microbiome, and inflammation. The findings are preliminary but point to several plausible mechanisms. This article summarizes what the evidence shows, what it does not yet prove, and what remains genuinely uncertain.
Key Takeaways
- Urolithin A is produced in the gut from ellagitannins by specific bacterial species — not everyone converts dietary polyphenols into urolithin A efficiently [8].
- Cell and animal studies suggest urolithin A may strengthen the intestinal barrier by activating Nrf2 antioxidant pathways and increasing mucus production [1] [6].
- Mitophagy — the selective removal of damaged mitochondria — is a proposed mechanism by which urolithin A may support gut epithelial cell resilience, though human gut-specific evidence is limited.
- A polyphenol-rich diet that supports urolithin A production may also favorably influence gut immune cells and microbial composition [5] [3].
- Most evidence comes from preclinical models; human clinical trials on urolithin A and gut health outcomes specifically remain limited.
How Urolithin A Is Made in the Gut
Urolithin A is not consumed directly from food — it is produced through a multi-step microbial conversion of ellagitannins and ellagic acid. A 2025 study published in Nature Communications identified specific gut bacteria responsible for a key step in this process: Enterocloster species encode a dehydroxylase enzyme that converts urolithin B into urolithin A [8]. This finding helps explain why urolithin A production varies so widely between individuals eating identical diets.
Because production depends on a relatively narrow set of bacterial species, a substantial portion of the population produces little or no urolithin A from diet alone. This has driven commercial interest in urolithin A supplements, though research on supplemental forms continues to evolve. It also highlights the broader point that gut microbiome composition shapes which polyphenol metabolites you actually absorb [3].
Urolithin A and the Intestinal Barrier
The intestinal barrier is a single layer of epithelial cells held together by tight junction proteins. When this barrier is compromised, bacterial endotoxins and other luminal contents can pass into circulation — a state sometimes described as increased intestinal permeability. Several studies have examined whether urolithin A can support or restore barrier integrity.
A 2019 paper in Nature Communications showed that urolithin A enhanced gut barrier integrity through activation of the Nrf2 pathway, a key regulator of antioxidant defense in epithelial cells [1]. A 2024 study in Scientific Reports found that urolithin A increased secretory mucin synthesis in intestinal cells, which thickens the protective mucus layer that sits above the epithelium [6]. Together, these studies suggest at least two distinct mechanisms — intracellular antioxidant signaling and physical mucus reinforcement — by which urolithin A might support barrier function.
Research has also tested urolithin A in contexts of barrier disruption. A 2022 study found that urolithin A attenuated gut barrier dysfunction caused by arsenic exposure, a model of chemically induced injury [2]. A separate 2022 study linked improved intestinal barrier function — via urolithin A’s effects on glycoprotein biosynthesis — to reduced cognitive impairment in a diabetic mouse model [4]. These are animal and cell studies; the degree to which findings translate to healthy human gut tissue remains to be established.
Effects on Gut Inflammation
Chronic low-grade intestinal inflammation is a feature of several conditions, and it interacts bidirectionally with barrier function. A 2023 study in Cell Death & Disease examined how a polyphenol-rich diet — producing metabolites including urolithin A — influenced the interplay between gut macrophages, neutrophils, and the microbiome in alleviating intestinal inflammation [5]. The study found that this interplay reduced inflammatory signaling, though attributing the effect solely to urolithin A from a diet study is difficult.
Urolithin A’s potential anti-inflammatory action in the gut appears to involve mitophagy — the selective removal of damaged mitochondria. When mitochondria deteriorate and are not cleared, they can release signals that trigger inflammatory cascades. Urolithin A is known to promote mitophagy, which may reduce this source of intracellular stress. A 2024 study in Nutrients investigated urolithin A’s effect on circadian rhythm disruption in the intestinal barrier caused by inflammation, finding that it helped restore circadian gene expression patterns alongside barrier markers [7].
Mitophagy: The Core Mechanism Connecting Urolithin A to Gut Cell Health
Mitophagy is the cell’s quality-control process for mitochondria — it tags and removes mitochondria that are damaged or no longer functioning efficiently, allowing cells to replace them with healthier versions. This process declines with age and under conditions of oxidative stress, which is relevant to the gut because intestinal epithelial cells have high energy demands and turnover quickly.
Urolithin A is one of a small number of naturally occurring compounds that has been shown to activate mitophagy in human cells. In the gut context, this matters because epithelial cells with compromised mitochondria are more susceptible to oxidative damage, barrier dysfunction, and inflammatory signaling. Supporting mitophagy may therefore be one way urolithin A contributes to gut cell resilience, though this mechanistic picture is still being assembled from preclinical work [1] [7].
It is worth noting that most mechanistic research on urolithin A and mitophagy has been conducted in muscle cells, where the evidence is more developed. The application of this mechanism to intestinal cells is scientifically plausible and supported by emerging data, but human clinical trials specifically examining urolithin A, mitophagy, and gut health outcomes are limited.
Urolithin A and the Gut Microbiome: A Two-Way Relationship
The relationship between urolithin A and the gut microbiome is bidirectional: the microbiome produces urolithin A, and urolithin A may in turn influence microbial composition and activity. A comprehensive 2023 review in Critical Reviews in Food Science and Nutrition summarized evidence on urolithin A’s sources, microbial biotransformation, and health effects, noting that changes in microbiome composition — including enrichment of certain beneficial species — have been associated with urolithin A production from ellagic acid-rich diets [3].
Whether supplemental urolithin A meaningfully reshapes the gut microbiome in humans is not well established. Most microbiome findings come from dietary intervention studies where multiple polyphenols are present simultaneously, making it difficult to isolate urolithin A’s specific contribution. Ongoing research in this area is expected to clarify the direction and magnitude of any microbiome-modulating effects.
What the Research Does Not Yet Show
Much of the research on urolithin A and gut health is preclinical — conducted in cell cultures or animal models of disease. While these studies establish plausible mechanisms, they do not directly demonstrate that taking a urolithin A supplement will improve gut barrier function or reduce inflammation in healthy adults. Human randomized controlled trials specifically targeting gut health outcomes with urolithin A are scarce.
Additionally, the studies cited here often examine urolithin A in the context of specific stressors — arsenic toxicity, diabetes, high-fat diet, circadian disruption. Extrapolating from these disease-state models to general gut health maintenance requires caution. The effective doses used in animal studies also do not map straightforwardly to human supplementation doses, and the long-term safety profile of high-dose supplemental urolithin A in humans has not been fully characterized.
🛒 Where to Buy Urolithin A
- Timeline Mitopure SoftgelsClinically studied
softgels, 500 mg/day — The clinically studied form (Amazentis); used in the human trials. - DoNotAge Pure Urolithin A
capsules, 250-500 mg — Popular longevity-brand generic, third-party tested. - ProHealth Longevity Urolithin A
capsules, 500 mg — Longevity-focused brand, often higher dose. - Double Wood Urolithin A
capsules, 250-500 mg — Budget-friendly, widely available, COA on request.
As an Amazon Associate we earn from qualifying purchases. Prices and availability vary; verify dose and third-party testing before buying.
A Note on the Evidence
The research on urolithin A and gut health is largely preclinical — most findings come from cell cultures and animal models, and human clinical trials focused on gut outcomes specifically are limited. Urolithin A supplements are not a treatment for any gastrointestinal condition, and this article is not medical advice. If you have a gut health concern, speak with a qualified healthcare provider before adding any supplement to your routine.
Frequently Asked Questions
How does urolithin A affect the gut barrier?
Preclinical research suggests two main mechanisms: activation of the Nrf2 antioxidant pathway in epithelial cells [1] and increased secretion of mucins that form the protective mucus layer [6]. Both effects could theoretically reduce permeability, but human clinical confirmation is still limited.
Does everyone produce urolithin A from their diet?
No. Urolithin A production requires specific gut bacteria. A 2025 study identified Enterocloster species as encoding the enzyme responsible for a critical step in urolithin A biosynthesis, and these bacteria are not equally abundant in all individuals [8]. People with low Enterocloster abundance may produce little or no urolithin A from pomegranate or walnut consumption.
What foods support urolithin A production?
Ellagitannins — the precursors to urolithin A — are found primarily in pomegranates, walnuts, and certain berries such as raspberries and strawberries. A review of urolithin A’s dietary sources and biotransformation notes that ellagic acid from these foods is the substrate that gut bacteria convert through a series of steps into urolithin A [3].
Has urolithin A been studied in the context of gut inflammation?
Yes, in preclinical settings. Research in a polyphenol-rich diet model found that microbially produced metabolites including urolithin A were associated with reduced intestinal inflammation through effects on macrophages, neutrophils, and the microbiome [5]. A 2024 study also found that urolithin A helped restore circadian gene expression and barrier markers in an inflammation-disrupted intestinal model [7].
What is the connection between urolithin A and mitophagy in the gut?
Mitophagy is the process by which cells clear damaged mitochondria. Urolithin A is a known activator of mitophagy, and intestinal epithelial cells with better mitochondrial quality may be more resilient to oxidative stress and inflammation. The 2019 Nature Communications study showing Nrf2 activation by urolithin A in gut epithelial cells [1] is consistent with this picture, though direct human gut mitophagy studies are not yet available.
Is urolithin A safe for gut health?
Available evidence from short-term human trials suggests urolithin A supplements are generally well tolerated, but long-term safety data in large populations is limited. People with inflammatory bowel disease, those taking immunosuppressive medications, or those with other gastrointestinal conditions should consult a healthcare provider before using urolithin A supplements.
References
- Singh R et al. Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway. Nature communications (2019). PMID 30626868
- Ghosh S et al. Urolithin A attenuates arsenic-induced gut barrier dysfunction. Archives of toxicology (2022). PMID 35122514
- Zhang M et al. Ellagic acid and intestinal microflora metabolite urolithin A: A review on its sources, metabolic distribution, health benefits, and biotransformation. Critical reviews in food science and nutrition (2023). PMID 35142569
- Xiao Y et al. Urolithin A Attenuates Diabetes-Associated Cognitive Impairment by Ameliorating Intestinal Barrier Dysfunction via N-glycan Biosynthesis Pathway. Molecular nutrition & food research (2022). PMID 35184377
- Han D et al. Polyphenol-rich diet mediates interplay between macrophage-neutrophil and gut microbiota to alleviate intestinal inflammation. Cell death & disease (2023). PMID 37813835
- Yasuda T et al. Urolithin A-mediated augmentation of intestinal barrier function through elevated secretory mucin synthesis. Scientific reports (2024). PMID 38977770
- Du Y et al. Effect of Urolithin A on the Improvement of Circadian Rhythm Dysregulation in Intestinal Barrier Induced by Inflammation. Nutrients (2024). PMID 39064706
- Pidgeon R et al. Diet-derived urolithin A is produced by a dehydroxylase encoded by human gut Enterocloster species. Nature communications (2025). PMID 39856097
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.
